MERCK'S ZOCOR PREFERRED BY 35% OF PHYSICIANS FOR PATIENTS WITH CHD, NHLBI CHOLESTEROL SURVEY FINDS; 5% OF U.S. TAKING CHOLESTEROL-LOWERING DRUG THERAPY
Executive Summary
Merck's Zocor is "preferred" by 35% of physicians for cholesterol-lowering in patients with coronary heart disease, according to the 1995 Cholesterol Awareness Survey conducted by the National Heart, Lung & Blood Institute.